Ukrainian medtech start-up DrugCard secures investment from New Nordic Ventures
The investment amount remains undisclosed
The Ukrainian medtech start-up, DrugCard, has entered into a partnership with the venture fund, New Nordic Ventures, securing a new financing round.
The start-up's CEO, Dmytro Horilyk, made this announcement.
Horilyk did not disclose the specific amount received from New Nordic Ventures.
"Even prior to formalising our collaboration, New Nordic Ventures provided us with valuable contacts in Latvia's pharmaceutical sector. This opened doors to key industry players in Latvia, granting us significant insights," he remarked.
Business angel Petro Chernyshov, who occasionally invests in early-stage Ukrainian start-ups, is also among DrugCard's investors.
DrugCard serves as an automatic platform for monitoring medical literature. It aids pharmaceutical companies by reducing costs, streamlining routine processes, and ensuring adherence to pharmacovigilance regulatory standards.
If you have read this article to the end, we hope that means it was useful for you.
We work to ensure that our journalistic and analytical work is of high quality, and we strive to perform it as competently as possible. This also requires financial independence. Support us for only UAH 196 per month.
Become a Mind subscriber for just USD 5 per month and support the development of independent business journalism!
You can unsubscribe at any time in your LIQPAY account or by sending us an email: [email protected]
